Details
Stereochemistry | ACHIRAL |
Molecular Formula | C24H24N2O4 |
Molecular Weight | 404.4584 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COCC1=C(N=CC2=C1C3=C(N2)C=CC(OCC4=CC=CC=C4)=C3)C(=O)OC(C)C
InChI
InChIKey=RLFKILXOLJVUNF-UHFFFAOYSA-N
InChI=1S/C24H24N2O4/c1-15(2)30-24(27)23-19(14-28-3)22-18-11-17(29-13-16-7-5-4-6-8-16)9-10-20(18)26-21(22)12-25-23/h4-12,15,26H,13-14H2,1-3H3
Molecular Formula | C24H24N2O4 |
Molecular Weight | 404.4584 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Abecarnil (isopropyl 6-benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate) is a nonselective mixed full agonist/partial agonist at GABA(A) receptor subtypes. Abecarnil possesses anxiolytic and anticonvulsant properties. Abecarnil has been studied in the treatment of anxiety disorders however its development has been discontinued.
CNS Activity
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Pharmacology of gamma-aminobutyric acidA receptor complex after the in vivo administration of the anxioselective and anticonvulsant beta-carboline derivative abecarnil. | 1992 Dec |
|
Antagonism of isoniazid-induced convulsions by abecarnil in mice tolerant to diazepam. | 1995 Oct |
|
Abecarnil, a beta-carboline derivative, does not exhibit anticonvulsant tolerance or withdrawal effects in mice. | 1996 Nov |
|
Use of negatively reinforcing electrical brain stimulation to detect conventional and nonconventional anxiolytics as well as an anxiogenic drug. | 2001 Jan |
|
Functional pharmacology of GABA(A) receptors containing the chicken brain gamma 4 subunit. | 2001 May 4 |
|
Synthesis of beta- and gamma-carbolines by the palladium-catalyzed iminoannulation of alkynes. | 2002 Dec 27 |
|
5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic. | 2002 Nov |
|
Psychopharmacology of anxiety disorders. | 2002 Sep |
|
Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site. | 2003 Aug |
|
Discriminative stimulus effects of positive GABAA modulators and other anxiolytics, sedatives, and anticonvulsants in untreated and diazepam-treated monkeys. | 2003 Jan |
|
Generalised anxiety disorder. | 2003 Jun |
|
Treating generalised anxiety disorder. | 2003 Mar 29 |
|
Neuroanatomical and pharmacological evidence for a functional interaction between GABAergic and NPY-Y1 transmission in the amygdala of Y1R/LacZ transgenic mice. | 2004 |
|
Generalised anxiety disorder. | 2004 Jun |
|
Anxioselective anxiolytics: can less be more? | 2004 Oct 1 |
|
The benzodiazepine binding site of GABA(A) receptors as a target for the development of novel anxiolytics. | 2005 May |
|
Anticipation and consumption of food each increase the concentration of neuroactive steroids in rat brain and plasma. | 2006 Sep |
|
The point mutation gamma 2F77I changes the potency and efficacy of benzodiazepine site ligands in different GABAA receptor subtypes. | 2010 Jun 25 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:57:25 GMT 2023
by
admin
on
Fri Dec 15 15:57:25 GMT 2023
|
Record UNII |
IZM1PNJ3JL
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C28197
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
6284
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY | |||
|
C062769
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY | |||
|
65914
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY | |||
|
CHEMBL87602
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY | |||
|
DTXSID40149745
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY | |||
|
ABECARNIL
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY | |||
|
IZM1PNJ3JL
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY | |||
|
m541
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000082324
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY | |||
|
SUB07360MIG
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY | |||
|
111841-85-1
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY | |||
|
C76501
Created by
admin on Fri Dec 15 15:57:25 GMT 2023 , Edited by admin on Fri Dec 15 15:57:25 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |